A5088761044- Dermatology and Skin Diseases
- Acne and Rosacea Treatments and Effects
- Genital Health and Disease
- Autoimmune Bullous Skin Diseases
- Herpesvirus Infections and Treatments
- Psoriasis: Treatment and Pathogenesis
- Colorectal and Anal Carcinomas
- Health Systems, Economic Evaluations, Quality of Life
- Cervical Cancer and HPV Research
- Nail Diseases and Treatments
- Cutaneous lymphoproliferative disorders research
- Nonmelanoma Skin Cancer Studies
- Cutaneous Melanoma Detection and Management
- HIV/AIDS Research and Interventions
- Dermatologic Treatments and Research
- Allergic Rhinitis and Sensitization
- HIV, Drug Use, Sexual Risk
- Clinical practice guidelines implementation
- Syphilis Diagnosis and Treatment
- Sex work and related issues
- Food Allergy and Anaphylaxis Research
- Urticaria and Related Conditions
- Reproductive tract infections research
- Asthma and respiratory diseases
- Dupuytren's Contracture and Treatments
Humboldt-Universität zu Berlin
1986-2025
Charité - Universitätsmedizin Berlin
2016-2025
Freie Universität Berlin
2017-2025
Zero to Three
2021
Ricardo (United Kingdom)
2017-2021
Berlin Institute of Health at Charité - Universitätsmedizin Berlin
2018-2020
ENT and Allergy
2018
Guideline Geo (Sweden)
2018
Berlin Heart (Germany)
2017
Doctors Company (United States)
2015
Abstract This evidence‐ and consensus‐based guideline was developed following the methods recommended by Cochrane Grading of Recommendations Assessment, Development Evaluation ( GRADE ) working group. The conference held on 1 December 2016. It is a joint initiative Dermatology Section European Academy Allergology Clinical Immunology EAACI ), EU ‐founded network excellence, Global Allergy Asthma Network GA ² LEN Forum EDF World Organization WAO with participation 48 delegates 42 national...
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by authors. Any queries (other than missing content) should be directed to corresponding author article.
This is a short summary of the complete version S3 European Acne guideline, please see online appendix for full text (Document S1. Long Version) and detailed methods report (DOI: 10.1111/jdv.13783). Expiry date: 31 December 2020 In order to grade recommendation "standardized guideline" language was used: Recommendations are based on available evidence expert consensus. Available voting lead classification strength recommendation. Adapalene + BPO (f.c.) or Clindamycin e Azelaic acid Topical...
Herpes zoster (HZ, shingles) is a frequent medical condition which may severely impact the quality of life affected patients. Different therapeutic approaches to treat acute HZ are available. The aim this European project was elaboration consensus-based guideline on management patients who present with HZ, considering different patient populations and localizations. This interdisciplinary aims at an improvement outcomes concerning disease duration, pain reduction in incidence postherpetic...
An update of the European S3-Guidelines on systemic treatment psoriasis vulgaris – Dermatology Forum (EDF) in cooperation with Academy and Venereology (EADV) International Psoriasis Council (IPC was published December 2015.1, 2 In addition to interventions discussed update, Committee for Medicinal Products Human Use (CHMP) Medicines Agency (EMA) approved apremilast secukinumab as new options psoriasis. The Commission granted a marketing authorization both treatments 15 January 2015.3, 4...
Abstract This guideline is an update of the 2011 European Guideline for Management Anogenital Warts. It intended to support best practice in care patients with anogenital warts by including evidence‐based recommendations on diagnosis, treatment, follow‐up and advice patients. use healthcare professionals sexual or dermato‐venereology clinics Europe but may be adapted other settings where management undertaken. As a guideline, should according national circumstances systems. Despite...
Summary The present guidelines are aimed at residents and board‐certified specialists in the fields of dermatology, ophthalmology, ENT, pediatrics, neurology, virology, infectious diseases, anesthesiology, general medicine any other medical specialties involved management patients with herpes zoster. They also intended as a guide for policymakers health insurance funds. were developed by dermatologists, virologists, ophthalmologists, ENT physicians, neurologists, pediatricians...
Lichen sclerosus (LS) is an inflammatory skin disease affecting all ages. LS typically involves the anogenital site where it causes itching and soreness; may lead to sexual urinary dysfunction in females males; however, be asymptomatic. First signs of are usually a whitening genital skin, sometimes preceded by redness oedema; fissuring, scarring, shrinkage fusion structures follow its course. associated with increased risk cancer. has huge impact on quality life affected patients, important...
Urethritis is a common condition predominantly caused by sexually transmitted pathogens such as Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium. It not possible to differentiate with certainty between on the basis of clinical characteristics alone. However, empirical antibiotic therapy often initiated in practice. The aim this practice guideline promote an evidence-based syndrome-orientated approach management male adolescents adults symptoms urethritis. Besides...
Abstract Herpes zoster ( HZ , shingles) is a frequent medical condition which may severely impact the quality of life affected patients. Different therapeutic approaches to treat acute are available. The aim this European project was elaboration consensus‐based guideline on management patients who present with considering different patient populations and localizations. This interdisciplinary aims at an improvement outcomes concerning disease duration, pain reduction incidence postherpetic...
Summary This guideline is an update from August 2020 the S2k‐guideline “Atopic dermatitis” published in 2015. The reason for updating this chapter of were current developments field systemic therapy atopic dermatitis. agreed recommendations treatment dermatitis present are based on scientific data. Due to approval dupilumab moderate severe dermatitis, which cannot be treated sufficiently with topical drugs alone, part has now been adapted and newly consented. indication therapeutic response...
Summary This updated and upgraded S2k guideline deals with the diagnosis treatment of rosacea, which is a common, chronic inflammatory skin disease mostly affecting face. Initially, rosacea characterized by recurrent erythema, telangiectasia flushing. Later, component predominates, persistent erythema follicular papules, papulopustules pustules. The development phyma, usually occurs on acral localizations, most severe manifestation. For interdisciplinary committee, representatives German...
Summary Over the past two decades, there has been a rise in incidence of syphilis, particularly among men who have sex with (MSM). This sparked interest studying prophylactic use doxycycline to prevent syphilis and other sexually transmitted infections (STIs), commonly referred as Doxycycline Pre‐ or Post‐Exposure Prophylaxis (Doxy‐PrEP, Doxy‐PEP). At same time, demand from potential users for this preventive measure is increasing. Several randomized controlled trials demonstrated that MSM...
Summary This S3 guideline was created based on the European guideline, with special consideration of medical conditions in German‐speaking region and incorporating additions from previous German‐language version. The interdisciplinary commission consisted representatives German Dermatological Society, Professional Association Dermatologists, Austrian Society Dermatology Venereology, Swiss for Allergology Clinical Immunology, Pediatric Adolescent Medicine, Pediatricians Environmental...
Abstract Background Cases of mpox have been reported worldwide since May 2022. Limited knowledge exists regarding the long-term course this disease. To assess sequelae in terms scarring and quality life (QoL) patients 4–6 months after initial infection. Methods Prospective observational study on clinical characteristics symptoms with polymerase chain reaction (PCR)-confirmed mpox, including both outpatients inpatients. Follow-up visits were conducted at months, assessing Patient Observer...
Anja Jacobs Alexander Nast Stefanie Rosumeck Ricardo Niklas Werner This document is the methods report to 'Update of evidence and consensus-based European S3-Guidelines systemic treatment psoriasis vulgaris'. The first edition these guidelines has been published in Journal Academy Dermatology Venereology.1 Please use following reference when citing guidelines: A, Gisondi P, Ormerod AD, Saiag Smith C, Spuls PI, Arenberger Bachelez H, Barker J, Dauden E, de Jong Feist Jobling R, Kemeny L,...